MedTrace Logo

Post Market Registry Study of the Philips QuickClear Mechanical Thrombectomy System

NCT05928221 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-02-06

No results posted yet for this study

Summary

A post-market study of the QuickClear Mechanical Thrombectomy system used for the removal of acute Deep Vein Thrombosis (DVT) from the deep veins of legs in the setting of an office interventional suite.

Conditions

  • Acute Deep Venous Thrombosis of Ileofemoral Vein

Interventions

DEVICE

Thrombectomy

removal of fresh soft emboli and thrombi from the vessels of the venous system

Sponsors & Collaborators

  • Paul J. Gagne

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-14
Primary Completion
2026-05-31
Completion
2026-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05928221 on ClinicalTrials.gov